Abbott India Limited carries a market capitalization of 567.89B, placing it among publicly traded companies globally. Its enterprise value stands at 528.55B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 567.89B |
| Enterprise Value | 528.55B |
Abbott India Limited currently has 21.25M shares outstanding.
| Shares Outstanding | 21.25M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Abbott India Limited trades at a trailing price-to-earnings ratio of 35.48. The price-to-sales ratio is 7.95, and the price-to-book ratio stands at 2,591.51.
| PE Ratio | 35.48 |
| PS Ratio | 7.95 |
| PB Ratio | 2,591.51 |
| P/TBV Ratio | 11.54 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Abbott India Limited trades at an EV/EBITDA multiple of 29.10 and an EV/FCF ratio of 2,833.59. The EV/Sales ratio of 7.63 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 29.10 provides insight into valuation relative to core operating earnings.
| EV / Sales | 7.63 |
| EV / EBITDA | 29.10 |
| EV / EBIT | 29.10 |
| EV / FCF | 2,833.59 |
Abbott India Limited maintains a current ratio of 2.55, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.60, indicating elevated leverage, while an interest coverage ratio of 72.67 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.55 |
| Quick Ratio | 1.62 |
| Debt / Equity | 3.60 |
| Debt / EBITDA | 0.09 |
| Interest Coverage | 72.67 |
Abbott India Limited posts a return on equity of 95.12 and a return on invested capital of 28.79.
| Return on Equity (ROE) | 95.12 |
| Return on Assets (ROA) | 24.99 |
| Return on Invested Capital (ROIC) | 28.79 |
| Return on Capital Employed (ROCE) | 86.49 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.04 |
Over the trailing twelve months, Abbott India Limited has paid 5.27B in income taxes, reflecting an effective tax rate of 25.36.
| Income Tax | 5.27B |
| Effective Tax Rate | 25.36 |
Abbott India Limited's stock has declined approximately -22.50254% over the past 52 weeks. The 50-day moving average sits at 26,433.90, while the 200-day moving average is 27,533.80.
| Beta (5Y) | N/A |
| 52-Week Price Change | -22.50254% |
| 50-Day Moving Average | 26,433.90 |
| 200-Day Moving Average | 27,533.80 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Abbott India Limited generated 69.29B in revenue and converted that into 15.52B in net income, yielding earnings per share of 730.36. EBITDA reached 18.16B, while operating income came in at 18.16B.
| Revenue | 69.29B |
| Gross Profit | 32.36B |
| Operating Income | 18.16B |
| Pretax Income | 20.79B |
| Net Income | 15.52B |
| EBITDA | 18.16B |
| EBIT | 18.16B |
| Earnings Per Share (EPS) | 730.36 |
Abbott India Limited holds 23.86B in cash and equivalents against 1.72B in total debt, resulting in a net debt position of -4.42B. Total book value stands at 212.50M, with working capital of 22.94B providing operational flexibility.
| Cash & Cash Equivalents | 23.86B |
| Total Debt | 1.72B |
| Net Debt | -4.42B |
| Equity (Book Value) | 212.50M |
| Book Value Per Share | 10.00 |
| Working Capital | 22.94B |
Abbott India Limited operates with a gross margin of 46.71, reflecting its pricing power and cost economics. The operating margin of 26.21 and net profit margin of 22.40 provide insight into operational efficiency.
| Gross Margin | 46.71 |
| Operating Margin | 26.21 |
| Pretax Margin | 30.01 |
| Profit Margin | 22.40 |
| EBITDA Margin | 26.21 |
Abbott India Limited posts an Altman Z-Score of 21.54, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 21.54 |